Drug-induced liver injury.
作者信息
Kumachev Alexander, Wu Peter E
机构信息
Department of Medicine (Kumachev, Wu) and Divisions of Clinical Pharmacology and Toxicology (Kumachev, Wu) and General Internal Medicine (Wu), University of Toronto, Toronto, Ont.
出版信息
CMAJ. 2021 Mar 1;193(9):E310. doi: 10.1503/cmaj.202026.
Abstract
摘要
相似文献
1
Drug-induced liver injury.药物性肝损伤
CMAJ. 2021 Mar 1;193(9):E310. doi: 10.1503/cmaj.202026.
2
[The diagnosis and treatment of drug-induced liver injury].[药物性肝损伤的诊断与治疗]
Zhonghua Gan Zang Bing Za Zhi. 2012 Mar;20(3):170-2.
3
Drug induced liver injury and vascular liver disease.药物性肝损伤和肝脏血管疾病。
Clin Res Hepatol Gastroenterol. 2020 Sep;44(4):471-479. doi: 10.1016/j.clinre.2020.03.020. Epub 2020 May 1.
4
Drug-Induced Liver Injury in Patients With Preexisting Chronic Liver Disease in Drug Development: How to Identify and Manage?药物研发中已有慢性肝病患者的药物性肝损伤：如何识别与处理？
Gastroenterology. 2016 Dec;151(6):1046-1051. doi: 10.1053/j.gastro.2016.10.010. Epub 2016 Oct 17.
5
[The cutting-edge of medicine: Diagnosis and treatment of drug-induced liver injury].[医学前沿：药物性肝损伤的诊断与治疗]
Nihon Naika Gakkai Zasshi. 2015 May 10;104(5):991-7. doi: 10.2169/naika.104.991.
6
[Drug-induced hepatitis: diagnosis and treatment].[药物性肝炎：诊断与治疗]
Gastroenterol Clin Biol. 1999 Aug-Sep;23(8-9):906-14.
7
[Expert panel consensus statement on prevention and standardized treatment of drug-induced liver injury in patients with blood diseases].[血液系统疾病患者药物性肝损伤预防及规范化治疗专家共识声明]
Zhonghua Xue Ye Xue Za Zhi. 2012 Mar;33(3):252-6.
8
LiverTox: a website on drug-induced liver injury.LiverTox：一个关于药物性肝损伤的网站。
Hepatology. 2013 Mar;57(3):873-4. doi: 10.1002/hep.26175.
9
[Drug induced liver injury].[药物性肝损伤]
Dtsch Med Wochenschr. 2016 Nov;141(23):1688-1691. doi: 10.1055/s-0042-107437. Epub 2016 Nov 17.
10
[Clinical Guidelines for Diagnosis and Treatment of Liver Injury Related to Chinese Herbal Medicine].《中药相关性肝损伤临床诊疗指南》
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2016 Jun;36(6):645-53.
引用本文的文献
1
Human Umbilical Cord Blood Plasma-Derived Exosomal miR-410-3p Alleviates Liver Injury by Regulating the Mitochondria-Mediated Antiapoptotic Signaling.人脐带血血浆来源的外泌体miR-410-3p通过调节线粒体介导的抗凋亡信号减轻肝损伤。
MedComm (2020). 2025 Aug 24;6(9):e70339. doi: 10.1002/mco2.70339. eCollection 2025 Sep.
2
Hepatotoxicity associated with statins: A retrospective pharmacovigilance study based on the FAERS database.他汀类药物相关肝毒性：一项基于FAERS数据库的回顾性药物警戒研究。
PLoS One. 2025 Jul 9;20(7):e0327500. doi: 10.1371/journal.pone.0327500. eCollection 2025.
3
GNF-5837 attenuates acute liver injury by inhibiting oxidative stress.GNF-5837通过抑制氧化应激减轻急性肝损伤。
Mol Biol Rep. 2025 Apr 21;52(1):407. doi: 10.1007/s11033-025-10522-2.
4
DIA-based quantitative proteomics explores the mechanism of amelioration of APAP-induced liver injury by anoectochilus roxburghii (Wall.) Lindl.基于数据非依赖采集的定量蛋白质组学探究金线莲改善对乙酰氨基酚诱导的肝损伤的机制。
Front Pharmacol. 2025 Mar 26;16:1508290. doi: 10.3389/fphar.2025.1508290. eCollection 2025.
5
Identification of key immune genes of drug-induced liver injury induced by tolvaptan based on bioinformatics.基于生物信息学的托伐普坦所致药物性肝损伤关键免疫基因的鉴定
Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr 3. doi: 10.1007/s00210-025-04084-0.
6
Safety Profile and Hepatotoxicity of Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitors: A Disproportionality Analysis Based on FDA Adverse Event Reporting System Database.间变性淋巴瘤激酶酪氨酸激酶抑制剂的安全性和肝毒性：基于美国食品药品监督管理局不良事件报告系统数据库的不成比例性分析
Toxics. 2025 Mar 14;13(3):210. doi: 10.3390/toxics13030210.
7
Insights into medication-induced liver injury: Understanding and management strategies.药物性肝损伤的见解：理解与管理策略。
Toxicol Rep. 2025 Mar 1;14:101976. doi: 10.1016/j.toxrep.2025.101976. eCollection 2025 Jun.
8
Clinical Safety of Pudilan Xiaoyan Oral Liquid for the Treatment of Upper Respiratory Tract Infection in the Real World: Protocol for a Prospective, Observational, Registry Study.蒲地蓝消炎口服液治疗上呼吸道感染在真实世界中的临床安全性：一项前瞻性、观察性、登记研究方案
JMIR Res Protoc. 2025 Mar 21;14:e65789. doi: 10.2196/65789.
9
Liver diseases: epidemiology, causes, trends and predictions.肝脏疾病：流行病学、病因、趋势及预测
Signal Transduct Target Ther. 2025 Feb 5;10(1):33. doi: 10.1038/s41392-024-02072-z.
10
Pharmacotherapy of Liver Fibrosis and Hepatitis: Recent Advances.肝纤维化和肝炎的药物治疗：最新进展
Pharmaceuticals (Basel). 2024 Dec 20;17(12):1724. doi: 10.3390/ph17121724.
本文引用的文献
1
Drug-Induced Liver Injury - Types and Phenotypes.药物性肝损伤——类型与表型
N Engl J Med. 2019 Jul 18;381(3):264-273. doi: 10.1056/NEJMra1816149.
2
EASL Clinical Practice Guidelines: Drug-induced liver injury.EASL 临床实践指南：药物性肝损伤。
J Hepatol. 2019 Jun;70(6):1222-1261. doi: 10.1016/j.jhep.2019.02.014. Epub 2019 Mar 27.
3
Drug-induced Liver Injury.药物性肝损伤
US Gastroenterol Hepatol Rev. 2010 Jan 1;6:73-80.
4
AASLD position paper: the management of acute liver failure.美国肝病研究学会立场文件：急性肝衰竭的管理
Hepatology. 2005 May;41(5):1179-97. doi: 10.1002/hep.20703.
Zotero 插件